The LipoMap™ test offers the most in-depth lipoprotein particle profiling currently available in clinical practice. Using cutting-edge nuclear magnetic resonance (NMR) spectroscopy, LipoMap™ delivers a sophisticated analysis of lipoprotein particles that goes far beyond traditional cholesterol testing. Instead of looking solely at LDL or HDL levels, this test measures the size, number, and density of lipoprotein particles—including LDL, HDL, VLDL, and IDL—as well as the distribution of free cholesterol and cholesterol esters within these particles.

This precision profiling reveals hidden cardiovascular risks that may not appear in standard lipid panels, making it an invaluable tool for early intervention and individualized treatment strategies.

• Key features:

  • LDL, HDL, VLDL, and IDL

  • Measures cholesterol content within each particle type

       

  • Detects advanced lipid patterns tied to genetic dyslipidemia, metabolic dysfunction, or insulin resistance

• Best suited for patients with:
  • Patients with persistent cardiovascular risk despite “normal” cholesterol readings

  • Individuals with complex lipid profiles or a strong family history of cardiovascular disease

       

  • Those with metabolic syndrome, prediabetes, or suspected insulin resistance